Literature DB >> 4145269

Practolol (Eraldin) eye drops as an ocular hypotensive agent.

J Vale, C I Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4145269      PMCID: PMC1215419          DOI: 10.1136/bjo.57.3.210

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  12 in total

1.  Topical propranolol and ocular tension in the human.

Authors:  J Vale; A C Gibbs; C I Phillips
Journal:  Br J Ophthalmol       Date:  1972-10       Impact factor: 4.638

2.  The effect of natural and synthetic vasopressins and other substances on active transport in ciliary epithelium of the rabbit.

Authors:  D F Cole; S Nagasubramanian
Journal:  Exp Eye Res       Date:  1972-01       Impact factor: 3.467

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  The effect of propranolol on human intraocular pressure.

Authors:  G Coté; S M Drance
Journal:  Can J Ophthalmol       Date:  1968-07       Impact factor: 1.882

5.  Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant.

Authors:  R T Brittain; J B Farmer; D Jack; L E Martin; W T Simpson
Journal:  Nature       Date:  1968-08-24       Impact factor: 49.962

6.  The effects of single instillations of isoproterenol on intraocular pressure in man.

Authors:  R A Ross; S M Drance
Journal:  Can J Ophthalmol       Date:  1969-10       Impact factor: 1.882

7.  A comparison of the ocular hypotensive actions of salbutamol and adrenaline in chronic simple glaucoma.

Authors:  G D Paterson; G Paterson
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

8.  Effects of norepinephrine, isoproterenol and sympathetic stimulation on aqueous humour dynamics in vervet monkeys.

Authors:  A Bill
Journal:  Exp Eye Res       Date:  1970-07       Impact factor: 3.467

9.  Propranolol as ocular hypotensive agent.

Authors:  C I Phillips; G Howitt; D J Rowlands
Journal:  Br J Ophthalmol       Date:  1967-04       Impact factor: 4.638

10.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

View more
  14 in total

1.  Atenolol eye drops.

Authors:  C I Phillips; M Macdonald; S M Gore; P M Cullen
Journal:  Br Med J       Date:  1976-12-11

2.  Medical treatment of open-angle glaucoma.

Authors: 
Journal:  Br Med J       Date:  1978-02-25

3.  The treatment of glaucoma: role of beta-blocking agents.

Authors:  W P Boger
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

4.  Effect of topical atenolol on intraocular pressure.

Authors:  K Wettrell; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

5.  Atenolol eye drops in glaucoma: a double-masked, controlled study.

Authors:  C I Phillips; S M Gore; M J Macdonald; P M Cullen
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

6.  Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.

Authors:  C Schmitt; V J Lotti; J C Le Douarec
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

7.  Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension.

Authors:  K Wettrell; K Wilke; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

8.  Atenolol versus adrenaline eye drops and an evaluation of these two combined.

Authors:  C I Phillips; S M Gore; P M Gunn
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

9.  Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug.

Authors:  F E Ros; C L Dake; N J Nagelkerke; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-06-19

10.  Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.

Authors:  F E Ros; C L Dake; L Offerhaus; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.